22 February 2024: Clinical Research
Effectiveness of Glutamine Oral Care in Reducing Oral Mucositis and Improving Oral Health After Neurosurgery: A Randomized Controlled Trial with Microbiome Analysis
Yan Gao DE , Hong Yang B , Xiaohong Zhang C , Ying Ma DF , Ling Wang AE*DOI: 10.12659/MSM.942585
Med Sci Monit 2024; 30:e942585
Table 3 General information.
| Control | Glutamine | Compound chlorhexidine | P | |
|---|---|---|---|---|
| Age | 48.57±17.36 | 50.93±15.18 | 50.13±14.43 | 0.5583 |
| Length of stay (day) | 12.07±8.86 | 10.82±6.81 | 11.81±8.34 | 0.5118 |
| Gender (n, %) | ||||
| Male | 59 (59.00%) | 61 (61.00%) | 60 (60.00%) | 0.9592 |
| Female | 41 (41.00%) | 39 (39.00%) | 40 (40.00%) | |
| Diagnosis (n, %) | ||||
| Cerebral hemorrhage | 52 (52.00%) | 49 (49.00%) | 50 (50.00%) | 0.9730 |
| Brain tumor | 34 (34.00%) | 39 (39.00%) | 37 (37.00%) | |
| Brain trauma | 6 (6.00%) | 7 (7.00%) | 7 (7.00%) | |
| Other | 8 (8.00%) | 5 (5.00%) | 6 (6.00%) | |
| Smoke (n, %) | 48 (48.00%) | 36 (36.00%) | 41 (41.00%) | 0.2243 |
| Hypertension (n, %) | 13 (13.00%) | 11 (11.00%) | 15 (15.00%) | 0.2731 |
| Alcohol use (n, %) | 22% | 25% | 23% | 0.1754 |
| BMI, kg/m | 23.70±3.89 | 24.31±3.97 | 23.91±4.22 | 0.5541 |